These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32260098)

  • 1. Female AhR Knockout Mice Develop a Minor Renal Insufficiency in an Adenine-Diet Model of Chronic Kidney Disease.
    Makhloufi C; Nicolas F; McKay N; Fernandez S; Hache G; Garrigue P; Brunet P; Guillet B; Burtey S; Poitevin S
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease.
    Sun N; Zhang Y; Ding L; An X; Bai F; Yang Y; Yu K; Fan J; Liu L; Yang H; Yang X
    J Mol Med (Berl); 2024 May; 102(5):679-692. PubMed ID: 38453697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease.
    Thome T; Vugman NA; Stone LE; Wimberly K; Scali ST; Ryan TE
    JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease.
    Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC
    Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway.
    Mo Y; Hu D; Yu W; Ji C; Li Y; Liu X; Lu Z
    J Ethnopharmacol; 2023 May; 308():116244. PubMed ID: 36764562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation.
    Ito S; Osaka M; Edamatsu T; Itoh Y; Yoshida M
    J Atheroscler Thromb; 2016 Aug; 23(8):960-75. PubMed ID: 26860885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
    Lu W; Cheng S; Xu J; Xiao Z; Yu Y; Xie Q; Fang Y; Chen R; Shen B; Xie Y; Ding X
    Toxicol Lett; 2024 May; 396():81-93. PubMed ID: 38670245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease induced by an adenine rich diet upregulates integrin linked kinase (ILK) and its depletion prevents the disease progression.
    de Frutos S; Luengo A; García-Jérez A; Hatem-Vaquero M; Griera M; O'Valle F; Rodríguez-Puyol M; Rodríguez-Puyol D; Calleros L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1284-1297. PubMed ID: 30726718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
    Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
    Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the aryl hydrocarbon receptor in endothelial cells improves ischemic angiogenesis in chronic kidney disease.
    Palzkill VR; Tan J; Yang Q; Morcos J; Laitano O; Ryan TE
    Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H44-H60. PubMed ID: 37921663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.
    Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L
    Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
    Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic aryl hydrocarbon receptor mediates chronic kidney disease-associated mental disorders involving GLT1 hypofunction and neuronal activity enhancement in the mouse brain.
    Huang YJ; Hung CC; Hsu PC; Lee PY; Tsai YA; Hsin YC; Lee XT; Chou CC; Chen ML; Tarng DC; Lee YH
    Glia; 2023 Apr; 71(4):1057-1080. PubMed ID: 36573349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan Metabolites Regulate Neuropentraxin 1 Expression in Endothelial Cells.
    Vial R; Poitevin S; McKay N; Burtey S; Cerini C
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells.
    Lano G; Laforêt M; Von Kotze C; Perrin J; Addi T; Brunet P; Poitevin S; Burtey S; Dou L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.